1. Home
  2. XRTX vs STSS Comparison

XRTX vs STSS Comparison

Compare XRTX & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • STSS
  • Stock Information
  • Founded
  • XRTX 2011
  • STSS 2017
  • Country
  • XRTX Canada
  • STSS United States
  • Employees
  • XRTX N/A
  • STSS N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • STSS Medical/Dental Instruments
  • Sector
  • XRTX Health Care
  • STSS Health Care
  • Exchange
  • XRTX Nasdaq
  • STSS Nasdaq
  • Market Cap
  • XRTX 5.0M
  • STSS 5.1M
  • IPO Year
  • XRTX N/A
  • STSS 2022
  • Fundamental
  • Price
  • XRTX $1.33
  • STSS $2.65
  • Analyst Decision
  • XRTX Strong Buy
  • STSS
  • Analyst Count
  • XRTX 1
  • STSS 0
  • Target Price
  • XRTX $14.00
  • STSS N/A
  • AVG Volume (30 Days)
  • XRTX 22.7K
  • STSS 92.3K
  • Earning Date
  • XRTX 11-29-2024
  • STSS 11-14-2024
  • Dividend Yield
  • XRTX N/A
  • STSS N/A
  • EPS Growth
  • XRTX N/A
  • STSS N/A
  • EPS
  • XRTX N/A
  • STSS N/A
  • Revenue
  • XRTX N/A
  • STSS N/A
  • Revenue This Year
  • XRTX N/A
  • STSS N/A
  • Revenue Next Year
  • XRTX N/A
  • STSS N/A
  • P/E Ratio
  • XRTX N/A
  • STSS N/A
  • Revenue Growth
  • XRTX N/A
  • STSS N/A
  • 52 Week Low
  • XRTX $1.09
  • STSS $2.34
  • 52 Week High
  • XRTX $7.00
  • STSS $18.15
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 41.92
  • STSS 37.57
  • Support Level
  • XRTX $1.29
  • STSS $2.54
  • Resistance Level
  • XRTX $1.42
  • STSS $2.99
  • Average True Range (ATR)
  • XRTX 0.15
  • STSS 0.28
  • MACD
  • XRTX -0.01
  • STSS 0.04
  • Stochastic Oscillator
  • XRTX 18.75
  • STSS 13.41

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Share on Social Networks: